Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics
Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such...
Ausführliche Beschreibung
Autor*in: |
Tao Chen [verfasserIn] Zhaowenbin Zhang [verfasserIn] Dong Weng [verfasserIn] LiQin Lu [verfasserIn] XiaoYa Wang [verfasserIn] Min Xing [verfasserIn] Hui Qiu [verfasserIn] MengMeng Zhao [verfasserIn] Li Shen [verfasserIn] Ying Zhou [verfasserIn] Jiang Chang [verfasserIn] Hui-Ping Li [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2021 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Bioactive Materials - KeAi Communications Co., Ltd., 2017, 6(2021), 10, Seite 3194-3206 |
---|---|
Übergeordnetes Werk: |
volume:6 ; year:2021 ; number:10 ; pages:3194-3206 |
Links: |
---|
DOI / URN: |
10.1016/j.bioactmat.2021.02.013 |
---|
Katalog-ID: |
DOAJ003138461 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ003138461 | ||
003 | DE-627 | ||
005 | 20230309173336.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.bioactmat.2021.02.013 |2 doi | |
035 | |a (DE-627)DOAJ003138461 | ||
035 | |a (DE-599)DOAJ0e9f94e7d56d4cfcb43c758e49abe5f4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a TA401-492 | |
050 | 0 | |a QH301-705.5 | |
100 | 0 | |a Tao Chen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such as macrophages. The ions released from bioceramics have shown the activity in stimulating soft tissue derived cells such as fibroblasts, endothelia cells and epithelia cells, and regulating macrophage polarization. Therefore, this study proposes an “ion therapy” approach based on the active ions of bioceramic materials, and investigates the therapeutic effect of bioactive ions derived from calcium silicate (CS) bioceramics on mouse models of pulmonary fibrosis. We demonstrate that silicate ions significantly reduce pulmonary fibrosis by simultaneously regulating the functions of AEC2 and macrophages. This result suggests potential clinical applications of ion therapy for lung fibrosis. | ||
650 | 4 | |a Silicate bioceramics | |
650 | 4 | |a Lung fibrosis | |
650 | 4 | |a Alveolar epithelial cells II | |
650 | 4 | |a Macrophages | |
653 | 0 | |a Materials of engineering and construction. Mechanics of materials | |
653 | 0 | |a Biology (General) | |
700 | 0 | |a Zhaowenbin Zhang |e verfasserin |4 aut | |
700 | 0 | |a Dong Weng |e verfasserin |4 aut | |
700 | 0 | |a LiQin Lu |e verfasserin |4 aut | |
700 | 0 | |a XiaoYa Wang |e verfasserin |4 aut | |
700 | 0 | |a Min Xing |e verfasserin |4 aut | |
700 | 0 | |a Hui Qiu |e verfasserin |4 aut | |
700 | 0 | |a MengMeng Zhao |e verfasserin |4 aut | |
700 | 0 | |a Li Shen |e verfasserin |4 aut | |
700 | 0 | |a Ying Zhou |e verfasserin |4 aut | |
700 | 0 | |a Jiang Chang |e verfasserin |4 aut | |
700 | 0 | |a Hui-Ping Li |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Bioactive Materials |d KeAi Communications Co., Ltd., 2017 |g 6(2021), 10, Seite 3194-3206 |w (DE-627)1663654956 |w (DE-600)2970496-0 |x 2452199X |7 nnns |
773 | 1 | 8 | |g volume:6 |g year:2021 |g number:10 |g pages:3194-3206 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.bioactmat.2021.02.013 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/0e9f94e7d56d4cfcb43c758e49abe5f4 |z kostenfrei |
856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S2452199X21000748 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2452-199X |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 6 |j 2021 |e 10 |h 3194-3206 |
author_variant |
t c tc z z zz d w dw l l ll x w xw m x mx h q hq m z mz l s ls y z yz j c jc h p l hpl |
---|---|
matchkey_str |
article:2452199X:2021----::oteayfumnrfboibihltooincouineie |
hierarchy_sort_str |
2021 |
callnumber-subject-code |
TA |
publishDate |
2021 |
allfields |
10.1016/j.bioactmat.2021.02.013 doi (DE-627)DOAJ003138461 (DE-599)DOAJ0e9f94e7d56d4cfcb43c758e49abe5f4 DE-627 ger DE-627 rakwb eng TA401-492 QH301-705.5 Tao Chen verfasserin aut Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such as macrophages. The ions released from bioceramics have shown the activity in stimulating soft tissue derived cells such as fibroblasts, endothelia cells and epithelia cells, and regulating macrophage polarization. Therefore, this study proposes an “ion therapy” approach based on the active ions of bioceramic materials, and investigates the therapeutic effect of bioactive ions derived from calcium silicate (CS) bioceramics on mouse models of pulmonary fibrosis. We demonstrate that silicate ions significantly reduce pulmonary fibrosis by simultaneously regulating the functions of AEC2 and macrophages. This result suggests potential clinical applications of ion therapy for lung fibrosis. Silicate bioceramics Lung fibrosis Alveolar epithelial cells II Macrophages Materials of engineering and construction. Mechanics of materials Biology (General) Zhaowenbin Zhang verfasserin aut Dong Weng verfasserin aut LiQin Lu verfasserin aut XiaoYa Wang verfasserin aut Min Xing verfasserin aut Hui Qiu verfasserin aut MengMeng Zhao verfasserin aut Li Shen verfasserin aut Ying Zhou verfasserin aut Jiang Chang verfasserin aut Hui-Ping Li verfasserin aut In Bioactive Materials KeAi Communications Co., Ltd., 2017 6(2021), 10, Seite 3194-3206 (DE-627)1663654956 (DE-600)2970496-0 2452199X nnns volume:6 year:2021 number:10 pages:3194-3206 https://doi.org/10.1016/j.bioactmat.2021.02.013 kostenfrei https://doaj.org/article/0e9f94e7d56d4cfcb43c758e49abe5f4 kostenfrei http://www.sciencedirect.com/science/article/pii/S2452199X21000748 kostenfrei https://doaj.org/toc/2452-199X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 6 2021 10 3194-3206 |
spelling |
10.1016/j.bioactmat.2021.02.013 doi (DE-627)DOAJ003138461 (DE-599)DOAJ0e9f94e7d56d4cfcb43c758e49abe5f4 DE-627 ger DE-627 rakwb eng TA401-492 QH301-705.5 Tao Chen verfasserin aut Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such as macrophages. The ions released from bioceramics have shown the activity in stimulating soft tissue derived cells such as fibroblasts, endothelia cells and epithelia cells, and regulating macrophage polarization. Therefore, this study proposes an “ion therapy” approach based on the active ions of bioceramic materials, and investigates the therapeutic effect of bioactive ions derived from calcium silicate (CS) bioceramics on mouse models of pulmonary fibrosis. We demonstrate that silicate ions significantly reduce pulmonary fibrosis by simultaneously regulating the functions of AEC2 and macrophages. This result suggests potential clinical applications of ion therapy for lung fibrosis. Silicate bioceramics Lung fibrosis Alveolar epithelial cells II Macrophages Materials of engineering and construction. Mechanics of materials Biology (General) Zhaowenbin Zhang verfasserin aut Dong Weng verfasserin aut LiQin Lu verfasserin aut XiaoYa Wang verfasserin aut Min Xing verfasserin aut Hui Qiu verfasserin aut MengMeng Zhao verfasserin aut Li Shen verfasserin aut Ying Zhou verfasserin aut Jiang Chang verfasserin aut Hui-Ping Li verfasserin aut In Bioactive Materials KeAi Communications Co., Ltd., 2017 6(2021), 10, Seite 3194-3206 (DE-627)1663654956 (DE-600)2970496-0 2452199X nnns volume:6 year:2021 number:10 pages:3194-3206 https://doi.org/10.1016/j.bioactmat.2021.02.013 kostenfrei https://doaj.org/article/0e9f94e7d56d4cfcb43c758e49abe5f4 kostenfrei http://www.sciencedirect.com/science/article/pii/S2452199X21000748 kostenfrei https://doaj.org/toc/2452-199X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 6 2021 10 3194-3206 |
allfields_unstemmed |
10.1016/j.bioactmat.2021.02.013 doi (DE-627)DOAJ003138461 (DE-599)DOAJ0e9f94e7d56d4cfcb43c758e49abe5f4 DE-627 ger DE-627 rakwb eng TA401-492 QH301-705.5 Tao Chen verfasserin aut Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such as macrophages. The ions released from bioceramics have shown the activity in stimulating soft tissue derived cells such as fibroblasts, endothelia cells and epithelia cells, and regulating macrophage polarization. Therefore, this study proposes an “ion therapy” approach based on the active ions of bioceramic materials, and investigates the therapeutic effect of bioactive ions derived from calcium silicate (CS) bioceramics on mouse models of pulmonary fibrosis. We demonstrate that silicate ions significantly reduce pulmonary fibrosis by simultaneously regulating the functions of AEC2 and macrophages. This result suggests potential clinical applications of ion therapy for lung fibrosis. Silicate bioceramics Lung fibrosis Alveolar epithelial cells II Macrophages Materials of engineering and construction. Mechanics of materials Biology (General) Zhaowenbin Zhang verfasserin aut Dong Weng verfasserin aut LiQin Lu verfasserin aut XiaoYa Wang verfasserin aut Min Xing verfasserin aut Hui Qiu verfasserin aut MengMeng Zhao verfasserin aut Li Shen verfasserin aut Ying Zhou verfasserin aut Jiang Chang verfasserin aut Hui-Ping Li verfasserin aut In Bioactive Materials KeAi Communications Co., Ltd., 2017 6(2021), 10, Seite 3194-3206 (DE-627)1663654956 (DE-600)2970496-0 2452199X nnns volume:6 year:2021 number:10 pages:3194-3206 https://doi.org/10.1016/j.bioactmat.2021.02.013 kostenfrei https://doaj.org/article/0e9f94e7d56d4cfcb43c758e49abe5f4 kostenfrei http://www.sciencedirect.com/science/article/pii/S2452199X21000748 kostenfrei https://doaj.org/toc/2452-199X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 6 2021 10 3194-3206 |
allfieldsGer |
10.1016/j.bioactmat.2021.02.013 doi (DE-627)DOAJ003138461 (DE-599)DOAJ0e9f94e7d56d4cfcb43c758e49abe5f4 DE-627 ger DE-627 rakwb eng TA401-492 QH301-705.5 Tao Chen verfasserin aut Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such as macrophages. The ions released from bioceramics have shown the activity in stimulating soft tissue derived cells such as fibroblasts, endothelia cells and epithelia cells, and regulating macrophage polarization. Therefore, this study proposes an “ion therapy” approach based on the active ions of bioceramic materials, and investigates the therapeutic effect of bioactive ions derived from calcium silicate (CS) bioceramics on mouse models of pulmonary fibrosis. We demonstrate that silicate ions significantly reduce pulmonary fibrosis by simultaneously regulating the functions of AEC2 and macrophages. This result suggests potential clinical applications of ion therapy for lung fibrosis. Silicate bioceramics Lung fibrosis Alveolar epithelial cells II Macrophages Materials of engineering and construction. Mechanics of materials Biology (General) Zhaowenbin Zhang verfasserin aut Dong Weng verfasserin aut LiQin Lu verfasserin aut XiaoYa Wang verfasserin aut Min Xing verfasserin aut Hui Qiu verfasserin aut MengMeng Zhao verfasserin aut Li Shen verfasserin aut Ying Zhou verfasserin aut Jiang Chang verfasserin aut Hui-Ping Li verfasserin aut In Bioactive Materials KeAi Communications Co., Ltd., 2017 6(2021), 10, Seite 3194-3206 (DE-627)1663654956 (DE-600)2970496-0 2452199X nnns volume:6 year:2021 number:10 pages:3194-3206 https://doi.org/10.1016/j.bioactmat.2021.02.013 kostenfrei https://doaj.org/article/0e9f94e7d56d4cfcb43c758e49abe5f4 kostenfrei http://www.sciencedirect.com/science/article/pii/S2452199X21000748 kostenfrei https://doaj.org/toc/2452-199X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 6 2021 10 3194-3206 |
allfieldsSound |
10.1016/j.bioactmat.2021.02.013 doi (DE-627)DOAJ003138461 (DE-599)DOAJ0e9f94e7d56d4cfcb43c758e49abe5f4 DE-627 ger DE-627 rakwb eng TA401-492 QH301-705.5 Tao Chen verfasserin aut Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such as macrophages. The ions released from bioceramics have shown the activity in stimulating soft tissue derived cells such as fibroblasts, endothelia cells and epithelia cells, and regulating macrophage polarization. Therefore, this study proposes an “ion therapy” approach based on the active ions of bioceramic materials, and investigates the therapeutic effect of bioactive ions derived from calcium silicate (CS) bioceramics on mouse models of pulmonary fibrosis. We demonstrate that silicate ions significantly reduce pulmonary fibrosis by simultaneously regulating the functions of AEC2 and macrophages. This result suggests potential clinical applications of ion therapy for lung fibrosis. Silicate bioceramics Lung fibrosis Alveolar epithelial cells II Macrophages Materials of engineering and construction. Mechanics of materials Biology (General) Zhaowenbin Zhang verfasserin aut Dong Weng verfasserin aut LiQin Lu verfasserin aut XiaoYa Wang verfasserin aut Min Xing verfasserin aut Hui Qiu verfasserin aut MengMeng Zhao verfasserin aut Li Shen verfasserin aut Ying Zhou verfasserin aut Jiang Chang verfasserin aut Hui-Ping Li verfasserin aut In Bioactive Materials KeAi Communications Co., Ltd., 2017 6(2021), 10, Seite 3194-3206 (DE-627)1663654956 (DE-600)2970496-0 2452199X nnns volume:6 year:2021 number:10 pages:3194-3206 https://doi.org/10.1016/j.bioactmat.2021.02.013 kostenfrei https://doaj.org/article/0e9f94e7d56d4cfcb43c758e49abe5f4 kostenfrei http://www.sciencedirect.com/science/article/pii/S2452199X21000748 kostenfrei https://doaj.org/toc/2452-199X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 6 2021 10 3194-3206 |
language |
English |
source |
In Bioactive Materials 6(2021), 10, Seite 3194-3206 volume:6 year:2021 number:10 pages:3194-3206 |
sourceStr |
In Bioactive Materials 6(2021), 10, Seite 3194-3206 volume:6 year:2021 number:10 pages:3194-3206 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Silicate bioceramics Lung fibrosis Alveolar epithelial cells II Macrophages Materials of engineering and construction. Mechanics of materials Biology (General) |
isfreeaccess_bool |
true |
container_title |
Bioactive Materials |
authorswithroles_txt_mv |
Tao Chen @@aut@@ Zhaowenbin Zhang @@aut@@ Dong Weng @@aut@@ LiQin Lu @@aut@@ XiaoYa Wang @@aut@@ Min Xing @@aut@@ Hui Qiu @@aut@@ MengMeng Zhao @@aut@@ Li Shen @@aut@@ Ying Zhou @@aut@@ Jiang Chang @@aut@@ Hui-Ping Li @@aut@@ |
publishDateDaySort_date |
2021-01-01T00:00:00Z |
hierarchy_top_id |
1663654956 |
id |
DOAJ003138461 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ003138461</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309173336.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.bioactmat.2021.02.013</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ003138461</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ0e9f94e7d56d4cfcb43c758e49abe5f4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">TA401-492</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QH301-705.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Tao Chen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such as macrophages. The ions released from bioceramics have shown the activity in stimulating soft tissue derived cells such as fibroblasts, endothelia cells and epithelia cells, and regulating macrophage polarization. Therefore, this study proposes an “ion therapy” approach based on the active ions of bioceramic materials, and investigates the therapeutic effect of bioactive ions derived from calcium silicate (CS) bioceramics on mouse models of pulmonary fibrosis. We demonstrate that silicate ions significantly reduce pulmonary fibrosis by simultaneously regulating the functions of AEC2 and macrophages. This result suggests potential clinical applications of ion therapy for lung fibrosis.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Silicate bioceramics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lung fibrosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Alveolar epithelial cells II</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Macrophages</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Materials of engineering and construction. Mechanics of materials</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biology (General)</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhaowenbin Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dong Weng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">LiQin Lu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">XiaoYa Wang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Min Xing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hui Qiu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">MengMeng Zhao</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li Shen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ying Zhou</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jiang Chang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hui-Ping Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Bioactive Materials</subfield><subfield code="d">KeAi Communications Co., Ltd., 2017</subfield><subfield code="g">6(2021), 10, Seite 3194-3206</subfield><subfield code="w">(DE-627)1663654956</subfield><subfield code="w">(DE-600)2970496-0</subfield><subfield code="x">2452199X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:6</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:10</subfield><subfield code="g">pages:3194-3206</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.bioactmat.2021.02.013</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/0e9f94e7d56d4cfcb43c758e49abe5f4</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S2452199X21000748</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2452-199X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">6</subfield><subfield code="j">2021</subfield><subfield code="e">10</subfield><subfield code="h">3194-3206</subfield></datafield></record></collection>
|
callnumber-first |
T - Technology |
author |
Tao Chen |
spellingShingle |
Tao Chen misc TA401-492 misc QH301-705.5 misc Silicate bioceramics misc Lung fibrosis misc Alveolar epithelial cells II misc Macrophages misc Materials of engineering and construction. Mechanics of materials misc Biology (General) Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics |
authorStr |
Tao Chen |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1663654956 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
TA401-492 |
illustrated |
Not Illustrated |
issn |
2452199X |
topic_title |
TA401-492 QH301-705.5 Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics Silicate bioceramics Lung fibrosis Alveolar epithelial cells II Macrophages |
topic |
misc TA401-492 misc QH301-705.5 misc Silicate bioceramics misc Lung fibrosis misc Alveolar epithelial cells II misc Macrophages misc Materials of engineering and construction. Mechanics of materials misc Biology (General) |
topic_unstemmed |
misc TA401-492 misc QH301-705.5 misc Silicate bioceramics misc Lung fibrosis misc Alveolar epithelial cells II misc Macrophages misc Materials of engineering and construction. Mechanics of materials misc Biology (General) |
topic_browse |
misc TA401-492 misc QH301-705.5 misc Silicate bioceramics misc Lung fibrosis misc Alveolar epithelial cells II misc Macrophages misc Materials of engineering and construction. Mechanics of materials misc Biology (General) |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Bioactive Materials |
hierarchy_parent_id |
1663654956 |
hierarchy_top_title |
Bioactive Materials |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1663654956 (DE-600)2970496-0 |
title |
Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics |
ctrlnum |
(DE-627)DOAJ003138461 (DE-599)DOAJ0e9f94e7d56d4cfcb43c758e49abe5f4 |
title_full |
Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics |
author_sort |
Tao Chen |
journal |
Bioactive Materials |
journalStr |
Bioactive Materials |
callnumber-first-code |
T |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2021 |
contenttype_str_mv |
txt |
container_start_page |
3194 |
author_browse |
Tao Chen Zhaowenbin Zhang Dong Weng LiQin Lu XiaoYa Wang Min Xing Hui Qiu MengMeng Zhao Li Shen Ying Zhou Jiang Chang Hui-Ping Li |
container_volume |
6 |
class |
TA401-492 QH301-705.5 |
format_se |
Elektronische Aufsätze |
author-letter |
Tao Chen |
doi_str_mv |
10.1016/j.bioactmat.2021.02.013 |
author2-role |
verfasserin |
title_sort |
ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics |
callnumber |
TA401-492 |
title_auth |
Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics |
abstract |
Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such as macrophages. The ions released from bioceramics have shown the activity in stimulating soft tissue derived cells such as fibroblasts, endothelia cells and epithelia cells, and regulating macrophage polarization. Therefore, this study proposes an “ion therapy” approach based on the active ions of bioceramic materials, and investigates the therapeutic effect of bioactive ions derived from calcium silicate (CS) bioceramics on mouse models of pulmonary fibrosis. We demonstrate that silicate ions significantly reduce pulmonary fibrosis by simultaneously regulating the functions of AEC2 and macrophages. This result suggests potential clinical applications of ion therapy for lung fibrosis. |
abstractGer |
Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such as macrophages. The ions released from bioceramics have shown the activity in stimulating soft tissue derived cells such as fibroblasts, endothelia cells and epithelia cells, and regulating macrophage polarization. Therefore, this study proposes an “ion therapy” approach based on the active ions of bioceramic materials, and investigates the therapeutic effect of bioactive ions derived from calcium silicate (CS) bioceramics on mouse models of pulmonary fibrosis. We demonstrate that silicate ions significantly reduce pulmonary fibrosis by simultaneously regulating the functions of AEC2 and macrophages. This result suggests potential clinical applications of ion therapy for lung fibrosis. |
abstract_unstemmed |
Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such as macrophages. The ions released from bioceramics have shown the activity in stimulating soft tissue derived cells such as fibroblasts, endothelia cells and epithelia cells, and regulating macrophage polarization. Therefore, this study proposes an “ion therapy” approach based on the active ions of bioceramic materials, and investigates the therapeutic effect of bioactive ions derived from calcium silicate (CS) bioceramics on mouse models of pulmonary fibrosis. We demonstrate that silicate ions significantly reduce pulmonary fibrosis by simultaneously regulating the functions of AEC2 and macrophages. This result suggests potential clinical applications of ion therapy for lung fibrosis. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
10 |
title_short |
Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics |
url |
https://doi.org/10.1016/j.bioactmat.2021.02.013 https://doaj.org/article/0e9f94e7d56d4cfcb43c758e49abe5f4 http://www.sciencedirect.com/science/article/pii/S2452199X21000748 https://doaj.org/toc/2452-199X |
remote_bool |
true |
author2 |
Zhaowenbin Zhang Dong Weng LiQin Lu XiaoYa Wang Min Xing Hui Qiu MengMeng Zhao Li Shen Ying Zhou Jiang Chang Hui-Ping Li |
author2Str |
Zhaowenbin Zhang Dong Weng LiQin Lu XiaoYa Wang Min Xing Hui Qiu MengMeng Zhao Li Shen Ying Zhou Jiang Chang Hui-Ping Li |
ppnlink |
1663654956 |
callnumber-subject |
TA - General and Civil Engineering |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1016/j.bioactmat.2021.02.013 |
callnumber-a |
TA401-492 |
up_date |
2024-07-03T16:12:21.797Z |
_version_ |
1803574985933979648 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ003138461</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309173336.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.bioactmat.2021.02.013</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ003138461</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ0e9f94e7d56d4cfcb43c758e49abe5f4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">TA401-492</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QH301-705.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Tao Chen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such as macrophages. The ions released from bioceramics have shown the activity in stimulating soft tissue derived cells such as fibroblasts, endothelia cells and epithelia cells, and regulating macrophage polarization. Therefore, this study proposes an “ion therapy” approach based on the active ions of bioceramic materials, and investigates the therapeutic effect of bioactive ions derived from calcium silicate (CS) bioceramics on mouse models of pulmonary fibrosis. We demonstrate that silicate ions significantly reduce pulmonary fibrosis by simultaneously regulating the functions of AEC2 and macrophages. This result suggests potential clinical applications of ion therapy for lung fibrosis.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Silicate bioceramics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lung fibrosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Alveolar epithelial cells II</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Macrophages</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Materials of engineering and construction. Mechanics of materials</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biology (General)</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhaowenbin Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dong Weng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">LiQin Lu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">XiaoYa Wang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Min Xing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hui Qiu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">MengMeng Zhao</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li Shen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ying Zhou</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jiang Chang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hui-Ping Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Bioactive Materials</subfield><subfield code="d">KeAi Communications Co., Ltd., 2017</subfield><subfield code="g">6(2021), 10, Seite 3194-3206</subfield><subfield code="w">(DE-627)1663654956</subfield><subfield code="w">(DE-600)2970496-0</subfield><subfield code="x">2452199X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:6</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:10</subfield><subfield code="g">pages:3194-3206</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.bioactmat.2021.02.013</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/0e9f94e7d56d4cfcb43c758e49abe5f4</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S2452199X21000748</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2452-199X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">6</subfield><subfield code="j">2021</subfield><subfield code="e">10</subfield><subfield code="h">3194-3206</subfield></datafield></record></collection>
|
score |
7.400197 |